Linda Clark spoke with Bloomberg Law about the emerging privacy regulations affecting neurotechnology companies. She emphasized the importance of early investment in privacy and ethics, stating, "The time to invest in this is now," as implementing safeguards becomes more challenging after data collection. The article discusses the regulatory landscape, highlighting state-led initiatives and potential compliance burdens for some companies. The article also addresses the need for companies to develop governance models and audit processes to align with their values and risk tolerance.
Read the full article.
